help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on November 19, 2009, doi:10.1164/rccm.200907-1008OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200907-1008OCv1
181/4/353    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Grydeland, T. B.
Right arrow Articles by Bakke, P. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grydeland, T. B.
Right arrow Articles by Bakke, P. S.
American Journal of Respiratory and Critical Care Medicine Vol 181. pp. 353-359, (2010)
© 2010 American Thoracic Society
doi: 10.1164/rccm.200907-1008OC


Original Article

Quantitative Computed Tomography Measures of Emphysema and Airway Wall Thickness Are Related to Respiratory Symptoms

Thomas B. Grydeland1,2, Asger Dirksen3, Harvey O. Coxson4, Tomas M. L. Eagan1,5, Einar Thorsen2,6, Sreekumar G. Pillai7, Sanjay Sharma8, Geir Egil Eide9,10, Amund Gulsvik1,2 and Per S. Bakke1,2

1 Department of Thoracic Medicine, Haukeland University Hospital and 2 Institute of Medicine, University of Bergen, Bergen, Norway; 3 Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark; 4 Department of Radiology and James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia, Vancouver, British Columbia, Canada; 5 Division of Physiology, Department of Medicine, University of California San Diego, San Diego, California; 6 Department of Occupational Medicine, Haukeland University Hospital, Bergen, Norway; 7 Pharmaceutical Exploratory Development, Hoffman-La Roche, Nutley, New Jersey; 8 Research and Development, GlaxoSmithKline, Research Triangle Park, North Carolina; 9 Center for Clinical Research, Haukeland University Hospital and 10 Research Group on Lifestyle Epidemiology, Department of Public Health and Primary Care, University of Bergen, Bergen, Norway

Correspondence and requests for reprints should be addressed to Thomas Grydeland, M.D., Department of Thoracic Medicine, Haukeland University Hospital, N-5021 Bergen, Norway. E-mail: thomas.grydeland{at}med.uib.no

Rationale: There is limited knowledge about the relationship between respiratory symptoms and quantitative high-resolution computed tomography measures of emphysema and airway wall thickness.

Objectives: To describe the ability of these measures of emphysema and airway wall thickness to predict respiratory symptoms in subjects with and without chronic obstructive pulmonary disease (COPD).

Methods: We included 463 subjects with chronic obstructive pulmonary disease (COPD) (65% men) and 488 subjects without COPD (53% men). All subjects were current or ex-smokers older than 40 years. They underwent spirometry and high-resolution computed tomography examination, and completed an American Thoracic Society questionnaire on respiratory symptoms.

Measurements and Main Results: Median (25th percentile, 75th percentile) percent low-attenuation areas less than –950 Hounsfield units (%LAA) was 7.0 (2.2, 17.8) in subjects with COPD and 0.5 (0.2, 1.3) in subjects without COPD. Mean (SD) standardized airway wall thickness (AWT) at an internal perimeter of 10 mm (AWT-Pi10) was 4.94 (0.33) mm in subjects with COPD and 4.77 (0.29) in subjects without COPD. Both %LAA and AWT-Pi10 were independently and significantly related to the level of dyspnea among subjects with COPD, even after adjustments for percent predicted FEV1. AWT-Pi10 was significantly related to cough and wheezing in subjects with COPD, and to wheezing in subjects without COPD. Odds ratios (95% confidence intervals) for increased dyspnea in subjects with COPD and in subjects without COPD were 1.9 (1.5–2.3) and 1.9 (0.6–6.6) per 10% increase in %LAA, and 1.07 (1.01–1.14) and 1.11 (0.99–1.24) per 0.1-mm increase in AWT-Pi10, respectively.

Conclusions: Quantitative computed tomography assessment of the lung parenchyma and airways may be used to explain the presence of respiratory symptoms beyond the information offered by spirometry.

Key Words: chronic obstructive pulmonary disease • computed tomography • dyspnea • cough • wheezing


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
There is limited knowledge about the association between respiratory symptoms and quantitative computed tomography (CT) measures of emphysema and airway wall thickness.

What This Study Adds to the Field
Quantitative CT measures of emphysema and airways may be used to explain the presence of respiratory symptoms in subjects with chronic obstructive pulmonary disease beyond the information available from spirometry alone. Level of dyspnea was predicted by quantitative CT measures of both emphysema and airway wall thickness, whereas the presence of coughing and wheezing was best predicted by airway wall thickness. There were only small sex differences.

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2010 American Thoracic Society